Mayne Pharma Group Ltd (ASX: MYX) Share Price and News
Price
Movement
52 Week Range
1 Year Return
() Chart and Price Data
Fundamental Company Figures
Data provided by Morningstar.Mayne Pharma Group Ltd (ASX: MYX) Latest News
Why IDP Education, IRESS, Mosaic Brands, & Mayne Pharma are dropping lower
James Mickleboro | August 21, 2020 12:46pm
The ASX stocks that could enjoy a consensus earnings upgrade this reporting season
Brendon Lau | August 10, 2020 4:28pm
These 2 ASX medical shares are on the rise after major announcements
Kate O'Brien | July 7, 2020 3:51pm
Why Electro Optic Systems, Mayne Pharma, Tyro, & WAM Leaders are racing higher
James Mickleboro | July 6, 2020 11:29am
Mayne Pharma share price on watch after announcing major Novast Laboratories agreement
James Mickleboro | July 6, 2020 9:26am
About Mayne Pharma Group Ltd (ASX: MYX)
Mayne Pharma Group Ltd (ASX: MYX) is a specialty pharmaceutical company that applies its drug delivery expertise to commercialise branded and generic pharmaceuticals. The company also provides contract development and manufacturing services to more than 100 clients worldwide.
Mayne Pharma is technology driven with a significant product portfolio and pipeline, and global reach through distribution partners in Australia, North America, Europe and Asia. The company has product development and manufacturing facilities in Salisbury, Australia and Greenville, North Carolina, USA with expertise in formulating complex oral and topical dose forms. The business is supported by more than 900 staff globally with more than 200 scientists employed.
The Salisbury facility is capable of developing products from formulation and clinical trial stages to validation and registration, right through to commercial scale manufacture of packaged goods.
Share Price History
Data provided by Morningstar.Date | Close | Change | % Change | Volume | Open | High | Low |
---|---|---|---|---|---|---|---|
24 Feb 2021 | $0.30 | $-0.02 | -6.45% | 4,547,645 | $0.30 | $0.31 | $0.29 |
23 Feb 2021 | $0.31 | $0.00 | 0.00% | 1,331,693 | $0.31 | $0.31 | $0.30 |
22 Feb 2021 | $0.31 | $0.01 | 3.28% | 1,478,559 | $0.30 | $0.31 | $0.30 |
19 Feb 2021 | $0.31 | $-0.01 | -3.23% | 2,081,619 | $0.31 | $0.32 | $0.30 |
18 Feb 2021 | $0.31 | $-0.01 | -3.17% | 1,923,683 | $0.32 | $0.32 | $0.31 |
17 Feb 2021 | $0.32 | $0.00 | 0.00% | 3,337,382 | $0.32 | $0.32 | $0.31 |
16 Feb 2021 | $0.32 | $-0.01 | -3.13% | 1,346,973 | $0.33 | $0.33 | $0.32 |
15 Feb 2021 | $0.32 | $-0.01 | -3.08% | 923,679 | $0.32 | $0.33 | $0.32 |
12 Feb 2021 | $0.33 | $0.01 | 3.13% | 990,386 | $0.32 | $0.33 | $0.32 |
11 Feb 2021 | $0.32 | $-0.01 | -3.08% | 860,688 | $0.32 | $0.33 | $0.32 |
10 Feb 2021 | $0.33 | $0.02 | 6.45% | 3,321,016 | $0.32 | $0.33 | $0.31 |
09 Feb 2021 | $0.31 | $-0.01 | -3.13% | 4,883,556 | $0.32 | $0.33 | $0.31 |
08 Feb 2021 | $0.32 | $-0.01 | -3.08% | 934,079 | $0.33 | $0.33 | $0.32 |
05 Feb 2021 | $0.33 | $-0.01 | -2.99% | 1,318,327 | $0.34 | $0.34 | $0.32 |
04 Feb 2021 | $0.34 | $0.00 | 0.00% | 827,030 | $0.33 | $0.34 | $0.33 |
03 Feb 2021 | $0.34 | $0.01 | 3.03% | 834,245 | $0.34 | $0.34 | $0.33 |
02 Feb 2021 | $0.33 | $0.02 | 6.35% | 1,349,872 | $0.32 | $0.34 | $0.32 |
01 Feb 2021 | $0.32 | $0.00 | 0.00% | 2,111,186 | $0.32 | $0.33 | $0.32 |
29 Jan 2021 | $0.32 | $-0.01 | -3.08% | 1,777,682 | $0.33 | $0.34 | $0.32 |
28 Jan 2021 | $0.33 | $-0.02 | -5.88% | 2,813,913 | $0.34 | $0.34 | $0.33 |
27 Jan 2021 | $0.34 | $-0.01 | -2.86% | 797,305 | $0.35 | $0.35 | $0.34 |
Director Transactions
Data provided by Morningstar.Directors & Management
Data provided by Morningstar.Top Share Holders
Data provided by Morningstar.Name | Shares | Capital |
---|---|---|
HSBC Custody Nominees (Australia) Limited | 320,478,060 | 19.10% |
Mr Bruce Mathieson And Related Entities | 105,577,583 | 6.30% |
J P Morgan Nominees Australia Pty Limited | 102,531,522 | 6.10% |
Citicorp Nominees Pty Limited | 97,467,463 | 5.80% |
Solium Nominees (Australia) Pty Ltd <Bare Allocated A/C> | 89,184,990 | 5.30% |
Estetra Sprl | 83,100,000 | 4.90% |
Solium Nominees (Australia) Pty Ltd <Unallocated A/C> | 29,692,951 | 1.80% |
BNP Paribas Nominees Pty Ltd <Agency Lending Drp A/C> | 26,688,048 | 1.60% |
IVL Group Pty Ltd | 16,000,000 | 1.00% |
BNP Paribas Noms Pty Ltd <Drp> | 14,106,094 | 0.80% |
Citicorp Nominees Pty Limited <Colonial First State Inv A/C> | 14,100,000 | 0.80% |
Australian Executor Trustees Limited <Ips Super A/C> | 11,327,284 | 0.70% |
Mr Roger Corbett And Related Entities | 10,440,569 | 0.60% |
National Nominees Limited | 10,278,401 | 0.60% |
Vivnat (Curtin) Pty Ltd | 10,000,000 | 0.60% |
Y S Chains Pty Ltd | 10,000,000 | 0.60% |
WAL Assets Pty Ltd <The La Wilson Property A/C> | 9,193,503 | 0.50% |
R & J Smith Shareholding Pty Ltd <R & J Smith Shareholding A/C> | 8,853,084 | 0.50% |
Mr Roger Aston & Related Entities | 7,140,935 | 0.40% |
William P Hodges | 6,089,554 | 0.40% |